Editorial: Targeting intra- and extracellular signals contributing to cancer stemness and metastasis in aggressive cancers, Volume II

Editorial: Targeting intra- and extracellular signals contributing to cancer stemness and metastasis in aggressive cancers, Volume II

Bibliographic Details
Main Authors:	Laia Caja, Enza Lonardo, Patricia Sancho
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Pharmacology
Subjects:	cancer stem cells cancer metabolism tumor microenvironment pancreatic ductal adenocarcinoma glioblastoma hepatocellular carcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1060359/full

Similar Items

Glucose and Amino Acid Metabolic Dependencies Linked to Stemness and Metastasis in Different Aggressive Cancer Types
by: Andrea Chisari, et al.
Published: (2021-09-01)

Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1
by: Jiawei Chang, et al.
Published: (2023-05-01)

Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
by: Adam S. Bryce, et al.
Published: (2022-10-01)

Targeting the Cancer–Neuronal Crosstalk in the Pancreatic Cancer Microenvironment
by: Ylenia Capodanno, et al.
Published: (2023-10-01)

The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies
by: Vincent M. Perez, et al.
Published: (2021-10-01)

Impact of tumour associated macrophages in pancreatic cancer
by: Ainhoa Mielgo, et al.
Published: (2013-03-01)

Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
by: Inga Hochnadel, et al.
Published: (2017-12-01)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
by: Jessica Allen, et al.
Published: (2020-10-01)

Pre-clinical Models of Metastasis in Pancreatic Cancer
by: Maria Miquel, et al.
Published: (2021-10-01)

The Role of Neural Signaling in the Pancreatic Cancer Microenvironment
by: Ryota Takahashi, et al.
Published: (2022-08-01)

Management of Metastatic Pancreatic Cancer—Comparison of Global Guidelines over the Last 5 Years
by: Monika Pajewska, et al.
Published: (2023-09-01)

Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell
by: Diana Tavares-Valente, et al.
Published: (2023-07-01)

Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
by: Tomohiko Taniai, et al.
Published: (2018-08-01)

Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer
by: Gabrielle Wishart, et al.
Published: (2021-06-01)

Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
by: Ruben Verloy, et al.
Published: (2020-09-01)

The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC
by: Dan Wang, et al.
Published: (2022-08-01)

A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions
by: Thomas Enzler, et al.
Published: (2024-03-01)

Pancreatic cancer‐derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP‐1 signaling pathways
by: Yu‐Ting Chang, et al.
Published: (2023-08-01)

A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes
by: Esteban Astiazaran-Symonds, et al.
Published: (2022-07-01)

The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer
by: Sherise Rogers, et al.
Published: (2023-12-01)

Unraveling the Connection: Pancreatic Cancer Cells and Schwann Cells
by: Ingrid Garajová, et al.
Published: (2024-03-01)

Current Screening Strategies for Pancreatic Cancer
by: Petr Vanek, et al.
Published: (2022-08-01)

Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
by: Jiajia Zhang, et al.
Published: (2018-01-01)

Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
by: Julianne M. Szczepanski, et al.
Published: (2024-02-01)

Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
by: Tatiana J. Carneiro, et al.
Published: (2022-08-01)

Dysregulation of intercellular communication in vitro and in vivo via extracellular vesicles secreted by pancreatic duct adenocarcinoma cells and generated under the influence of the AG9 elastin peptide‐conditioned microenvironment
by: Lise Nannan, et al.
Published: (2024-03-01)

Nomogram for Predicting Distant Metastasis of Pancreatic Ductal Adenocarcinoma: A SEER-Based Population Study
by: Weibo Li, et al.
Published: (2022-10-01)

Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
by: Maria Urbanova, et al.
Published: (2023-09-01)

Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
by: Bolun Jiang, et al.
Published: (2020-10-01)

The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer
by: Imke Stouten, et al.
Published: (2023-05-01)

Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma
by: Zhangyong Ren, et al.
Published: (2023-04-01)

Roles of microbiota in pancreatic cancer development and treatment
by: Mariana Santos Cruz, et al.
Published: (2024-12-01)

Harnessing the Microbiome to Reduce Pancreatic Cancer Burden
by: Ana Raquel Bastos, et al.
Published: (2023-05-01)

Bile Acids and Microbiota Interplay in Pancreatic Cancer
by: Pratibha Malhotra, et al.
Published: (2023-07-01)

Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
by: Aesha I. Ali, et al.
Published: (2019-02-01)

Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines
by: Laia Gorchs, et al.
Published: (2021-06-01)

Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients
by: Heidelinde Sammallahti, et al.
Published: (2021-11-01)

Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
by: Jakob Liermann, et al.
Published: (2022-05-01)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
by: Carol Cremin, et al.
Published: (2020-06-01)

Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management
by: Md. Ataur Rahman, et al.
Published: (2022-06-01)